
Malaria Consortium
Malaria Consortium is a global health non-profit that delivers and researches malaria prevention and treatment programs, including seasonal malaria chemoprevention, malaria vaccine delivery, disease surveillance and integrated child health services, in partnership with national governments in Africa and Asia. It’s work is rooted in responsive, on-the-ground solutions, working closely with governments, and particularly with sub-national and local authorities, to help to narrow the gap in health outcomes. Malaria Consortium US (MC-US), is the U.S.-based non-profit arm of Malaria Consortium. MC-US raises philanthropic funding and directs resources in the form of restricted or unrestricted grants for high-impact projects in countries where Malaria Consortium operates. These grants include interventions for malaria prevention and treatment, child health services, disease surveillance, vector control, and health system strengthening. These efforts are focused on saving lives and improving access to care in vulnerable communities. MC-US is managed and operated by three Malaria Consortium Officers and overseen by six independent volunteer Board of Directors.
What they do
Malaria Consortium is a global health non-profit that delivers and researches malaria prevention and treatment programs, including seasonal malaria chemoprevention, malaria vaccine delivery, disease surveillance and integrated child health services, in partnership with national governments in Africa and Asia. It’s work is rooted in responsive, on-the-ground solutions, working closely with governments, and particularly with sub-national and local authorities, to help to narrow the gap in health outcomes. Malaria Consortium US (MC-US), is the U.S.-based non-profit arm of Malaria Consortium. MC-US raises philanthropic funding and directs resources in the form of restricted or unrestricted grants for high-impact projects in countries where Malaria Consortium operates. These grants include interventions for malaria prevention and treatment, child health services, disease surveillance, vector control, and health system strengthening. These efforts are focused on saving lives and improving access to care in vulnerable communities. MC-US is managed and operated by three Malaria Consortium Officers and overseen by six independent volunteer Board of Directors.
- Hermitage, PAOther
In the field and in development
Partnerships in 8 endemic countries
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
- malaria vaccine research and implementation
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
- 18 districts in southern Ethiopia · accelerated reduction of malaria burden, with a reported 52% drop in cases and 65% drop in malaria deaths
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
- national review to optimize malaria surveillance2
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
- National Malaria Elimination Programme · co-developed the 2025 SMC coverage survey protocol
- Kano State · severe malaria diagnosis and management project
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
- national review to optimize malaria surveillance2
- National Malaria Programmes · implementing partner for seasonal malaria chemoprevention (SMC)
Who they work with in the United States
Where this comes from
- 1Malaria Consortium project list, Trustees report 2026
- 2MC-US FY25–FY26 Annual Report

